DK0639374T3 - Nye behandlingsmetoder ved anvendelse af phenethylderivater - Google Patents
Nye behandlingsmetoder ved anvendelse af phenethylderivaterInfo
- Publication number
- DK0639374T3 DK0639374T3 DK94304252T DK94304252T DK0639374T3 DK 0639374 T3 DK0639374 T3 DK 0639374T3 DK 94304252 T DK94304252 T DK 94304252T DK 94304252 T DK94304252 T DK 94304252T DK 0639374 T3 DK0639374 T3 DK 0639374T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- hydrogen
- disorder
- syndrome
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8384893A | 1993-06-28 | 1993-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0639374T3 true DK0639374T3 (da) | 2002-05-06 |
Family
ID=22181084
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01115854T DK1153603T3 (da) | 1993-06-28 | 1994-06-13 | Nye behandlingsmetoder ved anvendelse af phenethylaminderivater |
DK94304252T DK0639374T3 (da) | 1993-06-28 | 1994-06-13 | Nye behandlingsmetoder ved anvendelse af phenethylderivater |
DK06017469T DK1738753T3 (da) | 1993-06-28 | 1994-06-13 | Nye behandlinger under anvendelse af phenethylaminderivater |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01115854T DK1153603T3 (da) | 1993-06-28 | 1994-06-13 | Nye behandlingsmetoder ved anvendelse af phenethylaminderivater |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06017469T DK1738753T3 (da) | 1993-06-28 | 1994-06-13 | Nye behandlinger under anvendelse af phenethylaminderivater |
Country Status (15)
Country | Link |
---|---|
US (8) | US5916923A (fr) |
EP (3) | EP1153603B1 (fr) |
JP (2) | JPH0789851A (fr) |
KR (1) | KR100342762B1 (fr) |
AT (3) | ATE392893T1 (fr) |
AU (2) | AU6592994A (fr) |
CA (1) | CA2126305C (fr) |
CY (1) | CY2315B1 (fr) |
DE (3) | DE69429895T2 (fr) |
DK (3) | DK1153603T3 (fr) |
ES (3) | ES2273764T3 (fr) |
HK (1) | HK1038880B (fr) |
LV (1) | LV12881B (fr) |
PT (3) | PT1153603E (fr) |
SG (1) | SG47711A1 (fr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
EP0667150B1 (fr) * | 1994-02-14 | 2002-12-11 | Wyeth | Venlafaxine et ses analogues pour induire une amélioration des fonctions cognitives |
EP1331003B1 (fr) * | 1996-03-25 | 2015-08-26 | Wyeth LLC | Composition de venlafaxine à libération prolongée |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
US6579899B1 (en) | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
WO2000003701A1 (fr) * | 1998-07-16 | 2000-01-27 | Massachusetts Institute Of Technology | Composition pour le traitement du stress |
US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
PL350924A1 (en) * | 1999-04-06 | 2003-02-10 | Sepracor Inc | Derivatives of venlafaxine and methods of preparing and using the same |
US7291646B2 (en) | 1999-11-24 | 2007-11-06 | Wyeth | Ethers of O-desmethyl venlafaxine |
PL355502A1 (en) * | 1999-12-30 | 2004-05-04 | H.Lundbeck A/S | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
FR2807753B1 (fr) * | 2000-04-13 | 2002-06-07 | Adir | Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
ES2290281T5 (es) * | 2001-02-12 | 2017-09-11 | Wyeth Llc | Sal de succinato de O-desmetil-venlafaxina |
KR100421508B1 (ko) * | 2001-08-07 | 2004-03-09 | 김정한 | 항균 및 항진균 활성을 갖는 신규한 펜에틸아민 유도체와이의 염 |
UA77234C2 (en) * | 2001-12-05 | 2006-11-15 | Wyeth Corp | Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants) |
RU2004120285A (ru) * | 2001-12-05 | 2005-04-10 | Уайт (Us) | Новый кристаллический полиморф гидрохлорида венлафаксина и способы его получения |
AU2003226751A1 (en) | 2002-03-28 | 2003-10-13 | Synthon B.V. | Low water-soluble venlafaxine salts |
WO2003082806A1 (fr) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Base de venlafaxine |
AU2003219117A1 (en) * | 2002-03-28 | 2003-10-13 | Synthon B.V. | Extended release venlafaxine formulations |
AU2003221535A1 (en) | 2002-03-28 | 2003-10-13 | Synthon B.V. | Venlafaxine besylate |
US20040002500A1 (en) * | 2002-06-28 | 2004-01-01 | Fabre Kramer Pharmaceutical, Inc. | Methods for treating attention deficit disorder |
CA2507685A1 (fr) * | 2002-11-28 | 2004-06-10 | Themis Laboratories Private Limited | Procede de fabrication de microperles a liberation prolongee contenant de la venlafaxine hci |
US20070077301A1 (en) * | 2002-12-23 | 2007-04-05 | Meyer Glenn A | Venlafaxine osmotic device formulation |
WO2004075902A1 (fr) * | 2003-02-28 | 2004-09-10 | Amedis Pharmaceuticals Ltd. | Utilisation de derives de silicium de venlafaxine permettant de traiter ou de prevenir le psoriasis ou un trouble panique |
US20050048118A1 (en) * | 2003-07-25 | 2005-03-03 | Joan Cucala Escoi | Modified release venlafaxine hydrochloride tablets |
US7470435B2 (en) * | 2003-11-17 | 2008-12-30 | Andrx Pharmaceuticals, Llc | Extended release venlafaxine formulation |
US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
US20050142203A1 (en) * | 2003-12-30 | 2005-06-30 | Grant Heinicke | Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same |
US20050226923A1 (en) * | 2004-04-07 | 2005-10-13 | Gassert Chad M | Venlafaxine compositions in the form of microtablets |
US7776358B2 (en) * | 2004-07-22 | 2010-08-17 | Synthon Ip Inc. | Extended release venlafaxine besylate tablets |
WO2006094083A1 (fr) * | 2005-02-28 | 2006-09-08 | Penwest Pharmaceuticals Co. | Formulations de venlafaxine a liberation controlee |
CA2604916A1 (fr) * | 2005-04-22 | 2006-11-02 | Wyeth | Derives de dihydrobenzofurane et utilisations associees |
BRPI0610785A2 (pt) * | 2005-04-22 | 2016-09-13 | Wyeth Corp | polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição |
AU2006239918A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | New therapeutic combianations for the treatment or prevention of depression |
AU2006239922A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists |
JP2008538577A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
JP2009511641A (ja) * | 2005-10-19 | 2009-03-19 | テバ ファーマシューティカル インダストリーズ リミティド | 高純度1−〔2−ジメチルアミノ−(4−メトキシフェニル)エチル〕シクロヘキサノール塩酸塩の調製方法 |
EP1954669B1 (fr) * | 2005-12-01 | 2015-07-08 | Auspex Pharmaceuticals, Inc. | Phénétylamines substituées à l activité sérotoninergique et/ou norépinephrinergique |
JP2009518407A (ja) | 2005-12-05 | 2009-05-07 | ワイス | 置換1−(2−アミノ−1−フェニル−エチル)−シクロヘキサノールのエナンチオマーを選択的に合成するための方法 |
US20070225279A1 (en) * | 2006-03-24 | 2007-09-27 | Wyeth | Therapeutic combinations for the treatment of depression |
WO2007124045A2 (fr) * | 2006-04-20 | 2007-11-01 | Ampla Pharmaceuticals, Inc. | Potentialisation d'activité de récepteur mc4 |
US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
US20080261895A1 (en) * | 2006-10-25 | 2008-10-23 | Wyeth | Isolated hydroxy and n-oxide metabolites and derivatives of O-desmethylvenlafaxine and methods of treatment |
TW200846305A (en) * | 2007-03-15 | 2008-12-01 | Auspex Pharmaceuticals Inc | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
US20090048233A1 (en) * | 2007-08-16 | 2009-02-19 | Cypress Biosciences, Inc. | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
EP2222302A1 (fr) * | 2007-11-20 | 2010-09-01 | NeuroSearch A/S | Procédé de traitement des troubles d'hyperphagie |
KR100965527B1 (ko) | 2008-05-08 | 2010-06-23 | 제일약품주식회사 | 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물 |
CZ200969A3 (cs) * | 2009-02-06 | 2010-06-30 | Zentiva, K.S. | Nové soli desvenlafaxinu a zpusob jejich prípravy |
US9223364B2 (en) * | 2012-10-25 | 2015-12-29 | Inhon International Co., Ltd. | Heat dissipation control system for portable electrical device and control method thereof |
KR102132304B1 (ko) | 2020-02-17 | 2020-07-09 | 박광순 | 접이식 유아용 비데 |
RU2741226C1 (ru) * | 2020-09-08 | 2021-01-22 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) | Способ профилактики агрессии лиц с интернет-зависимостью |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4017637A (en) * | 1973-03-26 | 1977-04-12 | American Home Products Corporation | Benzylamine analgesics |
US3894051A (en) * | 1973-07-05 | 1975-07-08 | Colgate Palmolive Co | N-methylenedioxyphenylalkyl)-{62 -(alkyl)-disubstituted phenethylamines |
US4435449A (en) * | 1981-05-14 | 1984-03-06 | Burroughs Wellcome Co. | Treatment of minimal brain dysfunction (MBD) |
US4824868A (en) * | 1982-09-07 | 1989-04-25 | Ciba-Geigy Corporation | Propylamine derivatives useful for the treatment of dementia |
IE56324B1 (en) * | 1982-12-13 | 1991-06-19 | American Home Prod | Phenethylamine derivatives and intermediates therefor |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
AU566673B2 (en) * | 1983-09-15 | 1987-10-29 | F. Hoffmann-La Roche Ag | Phenethylamine derivatives |
US4611078A (en) * | 1983-10-26 | 1986-09-09 | American Home Products Corporation | Substituted phenylacetonitriles |
US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
US4609758A (en) * | 1985-05-09 | 1986-09-02 | American Home Products Corporation | Phenoxyethylamine derivatives |
US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
US5135947A (en) * | 1987-04-09 | 1992-08-04 | Eli Lilly And Company | 1-phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors |
DE3856295T2 (de) * | 1987-10-22 | 1999-06-17 | Massachusetts Institute Of Technology, Cambridge, Mass. | Behandlung des prämenstruellen oder späten lutealsphase-syndroms |
US4996235A (en) * | 1987-11-25 | 1991-02-26 | Eli Lilly And Company | 3,4-diphenylbutanamines |
US5013761A (en) * | 1988-06-03 | 1991-05-07 | Eli Lilly And Company | Serotonin antagonists |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US5057515A (en) * | 1989-07-24 | 1991-10-15 | Eli Lilly And Company | Method for agonizing a dopamine receptor |
US5006525A (en) * | 1989-07-24 | 1991-04-09 | Eli Lilly And Company | Dopamine agonists method |
FI910897A (fi) * | 1990-02-28 | 1991-08-29 | Lilly Co Eli | Foerbaettringar roerande (s)-norfluoxetin. |
CA2039103A1 (fr) * | 1990-03-29 | 1991-09-30 | David Wayne Robertson | Ameliorations relatives a l'occupation selective des recepteurs 1c de la serotonine et ameliorations connexes |
EP0612242B1 (fr) * | 1991-11-15 | 2003-07-09 | Sepracor Inc. | Utilisation de l' isomere s(+) pur de fluoxetine pour la preparation d'un medicament contre la migraine |
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
TW460478B (en) * | 1997-08-15 | 2001-10-21 | Chugai Pharmaceutical Co Ltd | Phenethylamine derivatives |
-
1994
- 1994-06-13 DE DE69429895T patent/DE69429895T2/de not_active Expired - Lifetime
- 1994-06-13 AT AT06017469T patent/ATE392893T1/de not_active IP Right Cessation
- 1994-06-13 ES ES01115854T patent/ES2273764T3/es not_active Expired - Lifetime
- 1994-06-13 DE DE69435095T patent/DE69435095T2/de not_active Revoked
- 1994-06-13 EP EP01115854A patent/EP1153603B1/fr not_active Revoked
- 1994-06-13 PT PT01115854T patent/PT1153603E/pt unknown
- 1994-06-13 SG SG1996003989A patent/SG47711A1/en unknown
- 1994-06-13 EP EP94304252A patent/EP0639374B1/fr not_active Expired - Lifetime
- 1994-06-13 DK DK01115854T patent/DK1153603T3/da active
- 1994-06-13 PT PT94304252T patent/PT639374E/pt unknown
- 1994-06-13 DK DK94304252T patent/DK0639374T3/da active
- 1994-06-13 DK DK06017469T patent/DK1738753T3/da active
- 1994-06-13 ES ES06017469T patent/ES2304041T3/es not_active Expired - Lifetime
- 1994-06-13 ES ES94304252T patent/ES2174864T3/es not_active Expired - Lifetime
- 1994-06-13 PT PT06017469T patent/PT1738753E/pt unknown
- 1994-06-13 AT AT94304252T patent/ATE213407T1/de active
- 1994-06-13 EP EP06017469A patent/EP1738753B1/fr not_active Revoked
- 1994-06-13 AT AT01115854T patent/ATE342715T1/de active
- 1994-06-13 DE DE69434872T patent/DE69434872T2/de not_active Expired - Lifetime
- 1994-06-20 JP JP6137282A patent/JPH0789851A/ja active Pending
- 1994-06-20 CA CA002126305A patent/CA2126305C/fr not_active Expired - Lifetime
- 1994-06-23 AU AU65929/94A patent/AU6592994A/en not_active Abandoned
- 1994-06-27 KR KR1019940014801A patent/KR100342762B1/ko not_active IP Right Cessation
-
1997
- 1997-04-08 US US08/835,780 patent/US5916923A/en not_active Expired - Lifetime
-
1998
- 1998-03-10 AU AU58312/98A patent/AU5831298A/en not_active Abandoned
-
1999
- 1999-04-02 US US09/285,812 patent/US6310101B1/en not_active Expired - Lifetime
-
2001
- 2001-01-25 US US09/769,998 patent/US6444708B2/en not_active Expired - Fee Related
- 2001-06-27 US US09/892,363 patent/US6465524B2/en not_active Expired - Fee Related
- 2001-11-30 US US09/996,590 patent/US6555586B2/en not_active Expired - Fee Related
-
2002
- 2002-01-18 HK HK02100415.5A patent/HK1038880B/zh not_active IP Right Cessation
- 2002-08-15 LV LVP-02-152A patent/LV12881B/en unknown
-
2003
- 2003-02-04 CY CY0300009A patent/CY2315B1/xx unknown
- 2003-03-25 US US10/396,043 patent/US6730706B2/en not_active Expired - Fee Related
- 2003-11-25 US US10/721,629 patent/US20040110829A1/en not_active Abandoned
-
2005
- 2005-12-07 JP JP2005353812A patent/JP2006117689A/ja active Pending
-
2007
- 2007-08-20 US US11/841,636 patent/US20080176950A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0639374T3 (da) | Nye behandlingsmetoder ved anvendelse af phenethylderivater | |
RU99111492A (ru) | N-замещенные 2-цианопирролидины | |
UA81413C2 (en) | Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives | |
ES2037779T3 (es) | Procedimiento para preparar nuevos compuestos de amida. | |
ATE413378T1 (de) | Verfahren zur herstellung von phenylethylaminen, insbesondere venlafaxin | |
ZA9811645B (en) | Acronycine compounds a process for their preparation and pharmaceutical compositions containing them | |
DK0667150T3 (da) | Venlafaxin og dens analoger til fremkaldelse af en forbedring af de kognitive funktioner | |
PT82527B (pt) | Processo para a preparacao de derivados de hidroxi-ciclo-alquil-fenoxi-etilamina | |
ATE52776T1 (de) | 1-phenyl-3-benzazepine. | |
MY106786A (en) | Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones |